Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
CD19/CD20 Dual-CAR-T in B-cell Leukemia Patients
ClinicalTrials.gov study NCT04260945. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety, Tolerability, and Pharmacokinetics of SHC014748M in Patients With Indolent B-Cell Hematologic Malignancies
ClinicalTrials.gov study NCT03588598. IPD Sharing: NO. Countries: 1. Publications: 0.
Clinical Study of CAR-iNKT Cells in the Treatment of Relapsed/Refractory/High-risk B-cell Tumors
ClinicalTrials.gov study NCT04814004. IPD Sharing: NO. Countries: 1. Publications: 0.
An Open and Dose-escalation Early Clinical Study of CD19 and CD20 CAR-T Cell Therapy for Relapsed or Refractory Aggressive B-cell Lymphoma
ClinicalTrials.gov study NCT07344818. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
The Efficacy and Safety of Glofitamab in Combination With PD-1 Antibody and Lenalidomide in Patients With Relapsed/Refractory Large B-cell Lymphoma (LBCL) With TP53 Aberrations: A Prospective, Multice
ClinicalTrials.gov study NCT07240194. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Purinostat Mesylate for Injection in the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL)
ClinicalTrials.gov study NCT05563844. IPD Sharing: NO. Countries: 1. Publications: 0.
Low Dose CdA Combined With Valproic Acid (VPA) in Previously Treated B-cell Chronic Lymphocytic Leukemia(B-CLL)
ClinicalTrials.gov study NCT01295593. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Regulatory B Cells in Inflammatory Rheumatisms and Biomarkers of Response to Biologic Treatments
ClinicalTrials.gov study NCT01642706. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Trial of ATG-101 in Patients With Metastatic/Advanced Solid Tumors and Mature B-cell Non-Hodgkin Lymphomas
ClinicalTrials.gov study NCT05490043. IPD Sharing: Not stated. Countries: 1. Publications: 0.
the Effect of Broken Ganoderma Lucidum Spore Powder on Quality of Life and Immune Function in Patients With Diffuse Large B-cell Lymphoma After Chemotherapy
ClinicalTrials.gov study NCT04914143. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma
ClinicalTrials.gov study NCT05852717. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of ONTAK in Patients With Relapsed or Refractory, B-Cell Non Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00211276. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Zanubrutinib and CAR T-cell Therapy for the Treatment of Recurrent or Refractory Aggressive B-cell Non-Hodgkin's Lymphoma or Transformed Indolent B-cell Lymphoma
ClinicalTrials.gov study NCT05202782. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase IB Study Of The BTKi CC-292 Combined With Lenalidomide In Adults Patients With Relapsed/Refractory B-Cell Lymphoma
ClinicalTrials.gov study NCT01766583. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT04442022. IPD Sharing: UNDECIDED. Countries: 7. Publications: 0.
CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/Refractory B Cell Malignancies
ClinicalTrials.gov study NCT04892277. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety, Efficacy and Pharmacokinetics of ThisCART19A in Patients With Refractory or Relapsed B Cell Lymphoma
ClinicalTrials.gov study NCT05776407. IPD Sharing: NO. Countries: 1. Publications: 0.
An Observational Study on the Safety Profile of MabThera/Rituxan (Rituximab) in Combination With Chemotherapy in Patients With B Cell-lineage Chronic Lymphocytic Leukaemia (MABERYC)
ClinicalTrials.gov study NCT01224093. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tafasitamab and Lenalidomide Followed by Tafasitamab and ICE as Salvage Therapy for Transplant Eligible Patients With Relapsed/ Refractory Large B-Cell Lymphoma
ClinicalTrials.gov study NCT05821088. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Efficacy Study of CNOP Chemotherapy in Diffuse Large B Cell Lymphoma
ClinicalTrials.gov study NCT02595242. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.